AVITI24 Platform Expansion

About Element Biosciences

Element Biosciences is a private, commercial-stage company that has established itself as a disruptive player in the next-generation sequencing (NGS) and multiomics market. Its core technology, the AVITI benchtop sequencer and the newer high-throughput VITARI platform, leverages proprietary Avidite Base Chemistry (ABC) to deliver accurate data with simplified workflows, including a novel Direct In Sample Sequencing (DISS) capability. The company is expanding into spatial biology and single-cell analysis with its AVITI24 system, positioning itself as an integrated platform provider. Backed by industry veteran leadership and notable customer testimonials from prestigious institutions, Element is focused on making advanced multiomic tools accessible to a broader range of research labs.